These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 18081151)
1. Impact of pre- and postoperative multimodality therapy on rectal cancer. Boller AM; Cima RR J Surg Oncol; 2007 Dec; 96(8):665-70. PubMed ID: 18081151 [TBL] [Abstract][Full Text] [Related]
2. [Advantages of neoadjuvant therapy in rectal neoplasm]. Nano M; Ferronato M; Solej M; D'Amico S G Chir; 2008 May; 29(5):197-202. PubMed ID: 18507953 [No Abstract] [Full Text] [Related]
5. Quality of life after rectal resection and multimodality therapy. Hassan I; Cima RR J Surg Oncol; 2007 Dec; 96(8):684-92. PubMed ID: 18081167 [TBL] [Abstract][Full Text] [Related]
6. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Daniels IR; Fisher SE; Heald RJ; Moran BJ Colorectal Dis; 2007 May; 9(4):290-301. PubMed ID: 17432979 [TBL] [Abstract][Full Text] [Related]
7. [Neoadjuvant treatment of rectal cancer: towards an individualised therapy]. Willeke F; Horisberger K; Post S Z Gastroenterol; 2006 Oct; 44(10):1053-63. PubMed ID: 17063435 [TBL] [Abstract][Full Text] [Related]
8. Should preoperative or postoperative therapy be administered in the management of rectal cancer? Kachnic LA Semin Oncol; 2006 Dec; 33(6 Suppl 11):S64-9. PubMed ID: 17178291 [TBL] [Abstract][Full Text] [Related]
9. The multidisciplinary management of rectal cancer. Meredith KL; Hoffe SE; Shibata D Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236 [TBL] [Abstract][Full Text] [Related]
10. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634 [TBL] [Abstract][Full Text] [Related]
11. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy. Lindebjerg J; Spindler KL; Ploen J; Jakobsen A Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119 [TBL] [Abstract][Full Text] [Related]
13. Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis. Neuman HB; Elkin EB; Guillem JG; Paty PB; Weiser MR; Wong WD; Temple LK Dis Colon Rectum; 2009 May; 52(5):863-71. PubMed ID: 19502849 [TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose. Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881 [TBL] [Abstract][Full Text] [Related]
15. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery]. Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy following neoadjuvant therapy of rectal cancer: the type of neoadjuvant therapy (chemoradiotherapy or radiotherapy) may be important for selection of patients. Fietkau R; Klautke G J Clin Oncol; 2008 Jan; 26(3):507-8; author reply 508-9. PubMed ID: 18202428 [No Abstract] [Full Text] [Related]
18. Rectal cancer adjuvant therapy controversies: When? What? Why? Rakinic J; Fry R Surg Oncol Clin N Am; 2000 Oct; 9(4):801-8; discussion 809-11. PubMed ID: 11008247 [TBL] [Abstract][Full Text] [Related]
19. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991 [TBL] [Abstract][Full Text] [Related]
20. Limitation of surgical radicality in rectal cancer responding to neoadjuvant therapy. Troja A; Hempen HG; Raab HR Onkologie; 2009 May; 32(5):286-90. PubMed ID: 19420978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]